Related Experiment Video
Updated: Jun 21, 2026
04:39
Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
Published on: March 17, 2023
The association between serum TSH concentration and thyroid cancer
1School of Clinical and Experimental Medicine, College of Medical and Dental Sciences, Institute of Biomedical Research, University of Birmingham, IBR Building 2nd Floor, Birmingham, UK. k.boelaert@bham.ac.uk
Endocrine-Related Cancer
|July 22, 2009
Summary
Elevated thyroid-stimulating hormone (TSH) levels predict thyroid cancer in patients with thyroid nodules. Lower TSH is linked to reduced papillary thyroid cancer risk, suggesting TSH
Area of Science:
- Endocrinology
- Oncology
- Thyroid Disease
Background:
- Serum thyroid-stimulating hormone (TSH) concentration is an independent predictor of thyroid malignancy in nodular thyroid disease.
- Higher preoperative TSH levels correlate with more aggressive thyroid tumors, suggesting TSH's role in differentiated thyroid cancer progression.
Purpose of the Study:
- To analyze the relationship between serum TSH and the diagnosis of papillary thyroid cancer.
- To investigate the association between TSH concentrations and thyroid cancer risk.
Main Methods:
- Analysis of serum TSH levels in 10,178 patients with nodular thyroid disease.
- Patients underwent fine-needle aspiration biopsy for diagnosis.
- Comparison of TSH concentrations between patients with thyroid cancer and benign thyroid disease.
Main Results:
- Significantly higher TSH concentrations were found in patients diagnosed with thyroid cancer compared to those with benign disease.
- Autonomous thyroid function (TSH < 0.4 mIU/mL) was associated with a reduced risk of papillary thyroid carcinoma.
Conclusions:
- Elevated serum TSH is associated with an increased risk of papillary thyroid cancer.
- Patients with higher TSH and borderline cytology may warrant more aggressive investigation and treatment.
- Autonomous thyroid function appears to have a protective effect against papillary thyroid carcinoma.
Related Concept Videos
01:20Synthesis and Regulation of Thyroid Hormones
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
01:27Goiter
Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...
01:25Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
01:27Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
01:28Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
01:24Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...